SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form CORRESP - Correspondence:
SEC Accession No. 0001193125-20-195268
Filing Date
2020-07-20
Accepted
2020-07-20 11:21:59
Documents
5

Document Format Files

Seq Description Document Type Size
1 filename1.htm CORRESP 11357
2 GRAPHIC g941279g54s12.jpg GRAPHIC 9751
3 GRAPHIC g941279g91e80.jpg GRAPHIC 1208
4 GRAPHIC g941279g91u41.jpg GRAPHIC 8413
5 GRAPHIC g941279g93t91.jpg GRAPHIC 10855
  Complete submission text file 0001193125-20-195268.txt   43670
Mailing Address SUITE 310, 815 W. HASTINGS STREET VANCOUVER A1 V6C 1B4
Business Address SUITE 310, 815 W. HASTINGS STREET VANCOUVER A1 V6C 1B4 (604) 669-7207
InMed Pharmaceuticals Inc. (Filer) CIK: 0001728328 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0630
Type: CORRESP
SIC: 2834 Pharmaceutical Preparations